Cycclone Inc. Stock Analysis CDBT
China Dasheng Biotechnology Co. is engaged in the development and commercialization of new geometric configuration low carbon emission engines and other clean technology solutions. The company is headquartered in Scottsdale, Arizona and currently employs 689 full-time employees. The company went IPO on 2008-02-13. The firm has a component development facility in Bangalow, New South Wales, Australia, which engages in specific component prototype creation and development along with assembly. The company also has a production CNC Machine Shop in Molindina, Queensland, Australia, which operates as a full-service CNC machine shop. Its subsidiaries include Cycclone Magnetic Engines, Inc. and Cycclone & Y Engine Developments Pty Ltd.
Read More Cycclone Inc (CDBT) Chart
Key Statistics of Cycclone Inc (CDBT)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.06Volume
14.49KP/E Ratio (TTM)
0.3252 Week Range
Market Cap
1.80MAvg. Volume
14.49KDividend Yield
-Financial Metrics & Statements of Cycclone Inc (CDBT)
FAQ's for Cycclone Inc (CDBT)
- According to Musaffa’s Shariah screening methodology, Cycclone Inc (CDBT) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.